Go Pro

Atea Pharmaceuticals (AVIR) Institutional Ownership

Atea Pharmaceuticals logo
$5.28 -0.36 (-6.38%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$5.28 +0.00 (+0.09%)
As of 09/23/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Atea Pharmaceuticals (NASDAQ:AVIR)

Current
Institutional Ownership
Percentage
86.67%
Number of
Institutional Buyers
(last 12 months)
42
Total
Institutional Inflows
(last 12 months)
$57.88M
Number of
Institutional Sellers
(last 12 months)
38
Total
Institutional Outflows
(last 12 months)
$8.62M
Get AVIR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Atea Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AVIR Institutional Buying and Selling by Quarter

Atea Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026 Opaleye Management Inc.235,000$1.09M0.1%-27.2%0.293%
9/9/2026 Engineers Gate Manager LP16,806$78K0.0%N/A0.021%
9/9/2026 Squarepoint Ops LLC29,316$136K0.0%-46.8%0.037%
9/8/2026 Spark Investment Management LLC16,200$75K0.1%N/A0.020%
8/20/2026 Headlands Technologies LLC16,619$77K0.0%N/A0.021%
8/19/2026 Hsbc Holdings PLC221,009$1.02M0.0%-14.7%0.276%
8/19/2026 Wellington Management Group LLP206,785$962K0.0%+262.7%0.258%
8/17/2026 Bank of America Corp DE81,730$380K0.0%N/A0.102%
8/14/2026 Hsbc Holdings PLC221,009$1.02M0.0%N/A0.276%
8/14/2026 Legal & General Group Plc7,082$33K0.0%N/A0.009%
8/14/2026 The Manufacturers Life Insurance Company17,698$82K0.0%N/A0.022%
8/14/2026 Algert Global LLC38,520$179K0.0%N/A0.048%
8/7/2026 BlackRock Inc.8,720,077$40.55M0.0%N/A10.896%
8/7/2026 Deutsche Bank AG70,400$327K0.0%N/A0.088%
8/6/2026 Bank of New York Mellon Corp189,452$881K0.0%N/A0.237%
6/16/2026 Empowered Funds LLC49,469$266K0.0%N/A0.062%
5/19/2026 Bank of America Corp DE105,640$568K0.0%-22.2%0.132%
5/19/2026 Irenic Capital Management LP301,699$1.62M0.1%N/A0.377%
5/18/2026 Empowered Funds LLC49,469$266K0.0%N/A0.062%
5/16/2026 The Manufacturers Life Insurance Company20,172$109K0.0%-15.8%0.025%
5/16/2026 Quantinno Capital Management LP15,950$86K0.0%N/A0.020%
5/15/2026 Rangeley Capital LLC46,500$250K0.2%-41.9%0.058%
5/14/2026 Renaissance Technologies LLC1,166,400$6.28M0.0%-1.9%1.457%
5/14/2026 Arrowstreet Capital Limited Partnership210,542$1.13M0.0%N/A0.263%
5/14/2026 Sei Investments Co.156,384$841K0.0%N/A0.195%
5/7/2026 Dimensional Fund Advisors LP1,255,484$6.75M0.0%-8.6%1.569%
5/6/2026 BML Capital Management LLC7,058,657$37.98M24.4%-5.8%8.820%
5/5/2026 Bank of New York Mellon Corp185,805$1M0.0%-6.4%0.232%
4/30/2026 Hsbc Holdings PLC258,989$1.38M0.0%+7.3%0.324%
4/25/2026 Strs Ohio96,400$519K0.0%-15.1%0.121%
3/20/2026 Hsbc Holdings PLC241,274$855K0.0%+16.9%0.303%
2/19/2026 Invesco Ltd.87,906$314K0.0%-29.3%0.113%
2/18/2026 XTX Topco Ltd10,439$37K0.0%-53.1%0.013%
2/18/2026 Wellington Management Group LLP242,840$867K0.0%-7.6%0.311%
2/18/2026 Tang Capital Management LLC4,814,700$17.19M0.8%-0.2%6.162%
2/18/2026 Opaleye Management Inc.179,815$642K0.1%N/A0.230%
2/18/2026 Millennium Management LLC698,156$2.49M0.0%+43.3%0.894%
2/18/2026 Bridgeway Capital Management LLC148,400$530K0.0%+3.7%0.190%
2/17/2026 Schonfeld Strategic Advisors LLC45,921$164K0.0%N/A0.059%
2/17/2026 Jump Financial LLC19,113$68K0.0%+36.5%0.024%
Elon gets it. Do you? (Ad)

Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.tc pixel

Stream the free Ignition Point broadcast for the full biotech breakdown.
2/17/2026 State of Wisconsin Investment Board91,245$326K0.0%-14.7%0.117%
2/17/2026 Graham Capital Management L.P.12,678$45K0.0%-81.9%0.016%
2/16/2026 Squarepoint Ops LLC19,311$69K0.0%N/A0.025%
2/13/2026 Marshall Wace LLP113,585$405K0.0%+30.5%0.145%
2/13/2026 The Manufacturers Life Insurance Company 23,967$86K0.0%-20.4%0.031%
2/13/2026 Charles Schwab Investment Management Inc.607,792$2.17M0.0%-2.8%0.778%
2/13/2026 Wells Fargo & Company MN79,794$285K0.0%+35.5%0.102%
2/12/2026 Jane Street Group LLC250,705$895K0.0%+54.6%0.321%
2/12/2026 HRT Financial LP47,891$170K0.0%+154.2%0.061%
2/12/2026 MetLife Investment Management LLC29,718$106K0.0%-35.3%0.038%
2/12/2026 Aldebaran Capital LLC90,529$323K0.3%N/A0.116%
2/12/2026 Renaissance Technologies LLC1,188,500$4.24M0.0%-3.2%1.521%
2/12/2026 Dimensional Fund Advisors LP1,373,946$4.91M0.0%-10.8%1.759%
2/12/2026 Alps Advisors Inc.64,154$229K0.0%+74.6%0.082%
2/12/2026 Nuveen LLC240,588$859K0.0%-6.0%0.308%
2/11/2026 Deutsche Bank AG52,714$188K0.0%N/A0.067%
2/11/2026 JPMorgan Chase & Co.1,348,294$4.81M0.0%+118.6%1.726%
2/10/2026 Goldman Sachs Group Inc.472,522$1.69M0.0%+38.9%0.605%
2/9/2026 Geode Capital Management LLC1,841,001$6.57M0.0%-3.1%2.356%
2/6/2026 EverSource Wealth Advisors LLC56,982$203K0.0%-62.2%0.073%
2/6/2026 Nano Cap New Millennium Growth Fund L P50,000$178K0.2%N/A0.064%
2/3/2026 RFG Advisory LLC14,875$53K0.0%N/A0.019%
2/3/2026 BML Capital Management LLC7,490,000$26.74M23.1%+0.2%9.587%
2/2/2026 CM Management LLC355,000$1.27M1.1%-29.0%0.454%
1/28/2026 Peapod Lane Capital LLC435,020$1.55M1.3%-4.9%0.557%
1/9/2026 SG Americas Securities LLC10,742$38K0.0%-47.5%0.014%
1/1/2026 JPMorgan Chase & Co.616,851$1.79M0.0%-5.5%0.790%
11/17/2025 Jacobs Levy Equity Management Inc.398,423$1.16M0.0%+37.2%0.510%
11/17/2025 Newtyn Management LLC492,284$1.43M0.2%-15.1%0.630%
11/17/2025 Millennium Management LLC487,223$1.41M0.0%+179.2%0.624%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.35,973$104K0.0%-14.3%0.046%
11/17/2025 Brevan Howard Capital Management LP29,450$85K0.0%-19.5%0.038%
11/17/2025 Bank of America Corp DE313,644$910K0.0%+185.8%0.401%
11/17/2025 Ameriprise Financial Inc.22,618$66K0.0%-33.0%0.029%
11/14/2025 Shay Capital LLC14,466$42K0.0%-56.1%0.018%
11/14/2025 Two Sigma Investments LP471,293$1.37M0.0%+28.6%0.594%
11/13/2025 BNP Paribas Financial Markets19,913$58K0.0%+57.7%0.025%
11/13/2025 Russell Investments Group Ltd.13,211$38K0.0%-60.3%0.017%
11/13/2025 Certified Advisory Corp24,500$71K0.0%N/A0.031%
11/12/2025 Dimensional Fund Advisors LP1,540,716$4.47M0.0%+9.2%1.941%
11/12/2025 Intech Investment Management LLC33,227$96K0.0%-25.5%0.042%
11/10/2025 EverSource Wealth Advisors LLC150,881$438K0.0%+60.6%0.190%
11/10/2025 Peapod Lane Capital LLC457,216$1.33M1.2%+1.0%0.576%
11/10/2025 BML Capital Management LLC7,473,963$21.67M16.7%-1.8%9.418%
11/10/2025 China Universal Asset Management Co. Ltd.13,910$40K0.0%-19.1%0.018%
11/7/2025Vanguard Group Inc.4,709,275$13.66M0.0%-3.6%5.934%
11/7/2025 JPMorgan Chase & Co.616,851$1.79M0.0%-5.5%0.777%
11/6/2025 Rhumbline Advisers113,612$329K0.0%-4.9%0.143%
11/5/2025 Alps Advisors Inc.36,751$107K0.0%-20.4%0.046%
10/23/2025 SG Americas Securities LLC20,461$59K0.0%N/A0.026%
I went to a party with Elon... (Ad)

Josh Baylin, a former Bloomberg tech reporter and ex-SAC Capital analyst, has spent weeks building a paper trail pointing to a new Elon-linked AI device. The FCC recently granted a key approval tied to the project, adding another data point to Baylin's research. His full report, along with the name and ticker of the stock he's watching, is available free.tc pixel

Download Josh Baylin's free report and stock pick now
10/9/2025 Voya Investment Management LLC16,449$48K0.0%-34.5%0.021%
8/15/2025 Shay Capital LLC32,954$119K0.0%-46.1%0.042%
8/15/2025 Rangeley Capital LLC53,000$191K0.2%N/A0.067%
8/15/2025 Oxford Asset Management LLP40,787$147K0.1%+83.7%0.051%
8/15/2025 BNP Paribas Financial Markets12,627$45K0.0%-85.0%0.016%
8/15/2025 Brevan Howard Capital Management LP36,567$132K0.0%N/A0.046%
8/15/2025 Bank of America Corp DE109,739$395K0.0%+80.9%0.138%
8/14/2025 Jane Street Group LLC70,395$253K0.0%-31.4%0.089%
8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.41,957$151K0.0%-9.0%0.053%
8/14/2025 RBF Capital LLC30,000$108K0.0%-33.2%0.038%


AVIR Institutional Ownership - Frequently Asked Questions

During the previous two years, 92 institutional investors and hedge funds held shares of Atea Pharmaceuticals. The most heavily invested institutionals were BlackRock Inc. ($40.55M), BML Capital Management LLC ($37.98M), FMR LLC ($22.17M), Tang Capital Management LLC ($17.19M), Vanguard Group Inc. ($13.66M), Dimensional Fund Advisors LP ($6.75M), and Geode Capital Management LLC ($6.57M).Learn more on Atea Pharmaceuticals' institutional investors.

86.67% of Atea Pharmaceuticals' stock is owned by institutional investors. Learn more on AVIR's institutional investor holdings.

Of the 79 institutional investors that purchased Atea Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($8.72M), BML Capital Management LLC ($1.25M), JPMorgan Chase & Co. ($1.09M), Millennium Management LLC ($546.17K), Peapod Lane Capital LLC ($456.81K), Bank of America Corp DE ($348.62K), and Dimensional Fund Advisors LP ($313.30K).

Institutional investors have bought a total of 13,100,971 shares in the last 24 months. This purchase volume represents approximately $57.88M in transactions.

Of the 38 institutional investors that sold Atea Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BML Capital Management LLC ($567.19K), Dimensional Fund Advisors LP ($285.23K), Vanguard Group Inc. ($177.95K), CM Management LLC ($145K), EverSource Wealth Advisors LLC ($93.90K), Newtyn Management LLC ($87.72K), and Opaleye Management Inc. ($87.60K).

Institutional investors have sold a total of 2,138,230 shares in the last 24 months. This volume of shares sold represents approximately $8.62M in transactions.



Institutional ownership data for NASDAQ:AVIR is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners